WALVAX BIOTECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.12 CNY | +0.20% |
|
+2.79% | -35.69% |
| Apr. 26 | Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024 | MT |
| Apr. 25 | Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial | MT |
Quotes 5-day view
End-of-day quote Shenzhen S.E.| 2024-04-29 | 2024-04-30 | 2024-05-06 | 2024-05-07 | 2024-05-08 | |
|---|---|---|---|---|---|
| Last | 14.84 ¥ | 14.71 ¥ | 14.97 ¥ | 15.09 ¥ | 15.12 ¥ |
| Volume | 24 744 060 | 14 246 000 | 18 034 850 | 15 723 950 | 22 231 000 |
| Change | +∞% | -0.88% | +1.77% | +0.80% | +0.20% |
| Opening | 14.35 | 14.83 | 14.90 | 14.98 | 15.10 |
| High | 14.88 | 14.84 | 15.20 | 15.23 | 15.37 |
| Low | 14.30 | 14.55 | 14.90 | 14.82 | 14.97 |
Performance
| 1 day | +0.20% | ||
| 1 week | +2.79% | ||
| Current month | +2.79% | ||
| 1 month | +0.73% | ||
| 3 months | -14.14% | ||
| 6 months | -38.03% | ||
| Current year | -35.69% | ||
| 1 year | -50.94% | ||
| 3 years | -72.86% | ||
| 5 years | -37.57% | ||
| 10 years | +175.23% |
Volumes
marketsDaily volume
22 231 000
Avg. Volume 20 sessions
18 329 693
Avg. Volume 20 sessions CNY
277 144 958.16
Avg. Volume 20 sessions USD
38 357 693.64
Record volume 1
268 063 200
Record volume 2
239 207 300
Record volume 3
162 313 000
Capital turnover ratio
0.01
Float rotation
0.04
Basic data
Capitalization (CNY)
24 163 522 135
Capitalization (USD)
3 344 303 954
Net sales (CNY)
4 113 772 330
Net sales (USD)
569 358 432
Number of employees
2 388
Sales / Employee (CNY)
1 722 685
Sales / Employee (USD)
238 425
Free-Float
27.42 %
Free-Float capitalization (CNY)
6 691 403 997
Free-Float capitalization (USD)
926 110 387
Average Daily Capital Traded
1.15%
Highs and lows
1 week
14.82
15.37
1 month
13.1315.37
Current year
13.1323.66
1 year
13.1331.00
3 years
13.1396.73
5 years
13.1396.73
10 years
5.0596.73
Indicators
Moving average 5 days
14.95
Moving average 20 days
14.52
Moving average 50 days
16.26
Moving average 100 days
18.46
Price spread / (MMA5)
-1.12%
Price spread / (MMA20)
-3.97%
Price spread / (MMA50)
+7.54%
Price spread / (MMA100)
+22.09%
STIM
RSI 9 days
58.30
RSI 14 days
49.99
Sector Comparison - Biopharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.20% | +2.79% | -35.69% | -50.94% | 3.34B | ||
| -1.39% | +0.23% | -3.71% | -7.94% | 89.33B | ||
| +0.76% | +1.28% | +4.08% | +0.38% | 41.19B | ||
| +0.37% | +1.66% | -15.09% | -30.11% | 31.87B | ||
| +1.13% | -2.65% | +53.68% | +44.97% | 24.52B | ||
| -0.91% | -1.80% | -15.13% | -14.71% | 15.68B | ||
| -2.25% | +0.54% | -8.63% | -2.87% | 12.34B | ||
| -1.22% | +3.79% | -40.39% | -29.22% | 12.23B | ||
| +1.00% | -0.63% | +6.22% | +9.16% | 8.83B | ||
| +0.12% | -4.54% | -6.55% | +2.83% | 8.28B | ||
| -5.91% | -7.88% | -6.45% | +4.61% | 7.52B | ||
| -1.80% | -1.58% | +76.75% | +284.75% | 6.93B | ||
| +0.33% | +4.31% | -3.01% | +10.17% | 6.83B | ||
| +1.36% | +3.76% | -6.88% | +10.86% | 6.73B | ||
| +0.43% | +7.86% | -39.66% | -2.12% | 5.99B | ||
| -3.64% | -8.14% | -29.34% | -53.71% | 5.32B | ||
| Average | -0.73% | +0.37% | -4.36% | +11.01% | ||
| Weighted average by Cap. | -0.57% | +0.54% | -0.91% | +2.13% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -35.69% | ||
| 2023 | -41.50% | ||
| 2022 | -28.49% | ||
| 2021 | +45.75% | ||
| 2020 | +18.87% | ||
| 2019 | +69.84% | ||
| 2018 | +4.66% | ||
| 2017 | +67.43% | ||
| 2016 | -17.30% | ||
| 2015 | +95.89% | ||
| 2014 | +34.60% | ||
| 2013 | +4.39% | ||
| 2012 | -1.73% | ||
| 2011 | -48.64% | ||
| 2010 | -2.31% |
- Stock Market
- Equities
- 300142 Stock
- Quotes Walvax Biotechnology Co., Ltd.